AP945A - Encapsulated solution dosage forms of sertraline. - Google Patents
Encapsulated solution dosage forms of sertraline. Download PDFInfo
- Publication number
- AP945A AP945A APAP/P/1998/001279A AP9801279A AP945A AP 945 A AP945 A AP 945A AP 9801279 A AP9801279 A AP 9801279A AP 945 A AP945 A AP 945A
- Authority
- AP
- ARIPO
- Prior art keywords
- sertraline
- dosage form
- mga
- oil
- vehicle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5140197P | 1997-07-01 | 1997-07-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9801279A0 AP9801279A0 (en) | 1998-06-30 |
| AP945A true AP945A (en) | 2001-02-28 |
Family
ID=21971076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1998/001279A AP945A (en) | 1997-07-01 | 1998-06-25 | Encapsulated solution dosage forms of sertraline. |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP0980241B1 (zh) |
| JP (1) | JP3585245B2 (zh) |
| KR (1) | KR100371730B1 (zh) |
| CN (1) | CN1261792A (zh) |
| AP (1) | AP945A (zh) |
| AR (1) | AR015916A1 (zh) |
| AT (1) | ATE256457T1 (zh) |
| AU (1) | AU724635B2 (zh) |
| BG (1) | BG103917A (zh) |
| BR (1) | BR9809712A (zh) |
| CA (1) | CA2290973C (zh) |
| CO (1) | CO4940405A1 (zh) |
| DE (1) | DE69820608T2 (zh) |
| DK (1) | DK0980241T3 (zh) |
| DZ (1) | DZ2544A1 (zh) |
| EA (1) | EA001905B1 (zh) |
| ES (1) | ES2210760T3 (zh) |
| GT (1) | GT199800090A (zh) |
| HR (1) | HRP980378B1 (zh) |
| HU (1) | HUP0002250A3 (zh) |
| ID (1) | ID24673A (zh) |
| IL (1) | IL133075A0 (zh) |
| IS (1) | IS5266A (zh) |
| MA (1) | MA24586A1 (zh) |
| MY (1) | MY119728A (zh) |
| NO (1) | NO996492L (zh) |
| NZ (1) | NZ501252A (zh) |
| OA (1) | OA11246A (zh) |
| PA (1) | PA8454001A1 (zh) |
| PE (1) | PE97299A1 (zh) |
| PL (1) | PL337807A1 (zh) |
| PT (1) | PT980241E (zh) |
| SK (1) | SK282914B6 (zh) |
| TN (1) | TNSN98123A1 (zh) |
| TR (1) | TR199903282T2 (zh) |
| TW (1) | TW382597B (zh) |
| UA (1) | UA68350C2 (zh) |
| UY (1) | UY25070A1 (zh) |
| WO (1) | WO1999001113A1 (zh) |
| ZA (1) | ZA985709B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL348119A1 (en) * | 1998-10-13 | 2002-05-06 | Pfizer Prod Inc | Sertraline oral concentrate |
| US6727283B2 (en) | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
| EP1889614A3 (en) | 1999-09-03 | 2010-09-22 | APBI Holdings, LLC | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| AU2001276608A1 (en) | 2000-08-30 | 2002-03-13 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
| EP1375659A1 (en) * | 2002-06-18 | 2004-01-02 | Laboratorio di Diagnostica Moleculare | Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions |
| CN1728982A (zh) * | 2002-10-31 | 2006-02-01 | 阿尔扎公司 | 可增加疏水性药物生物利用度的药物制剂 |
| WO2016020936A2 (en) * | 2014-07-21 | 2016-02-11 | Patel Jayendrakumar Dasharathlal | A novel oral gastroretentive pharmaceutical dosage form |
| CN108014087A (zh) * | 2017-12-27 | 2018-05-11 | 江苏联环药业股份有限公司 | 一种盐酸舍曲林胶囊的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996009047A1 (en) * | 1994-09-19 | 1996-03-28 | The Du Pont Merck Pharmaceutical Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| EP0768083A2 (en) * | 1995-07-17 | 1997-04-16 | Pfizer Inc. | The use of sertraline to treat post myocardial infarction patients |
-
1998
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active IP Right Cessation
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Application Discontinuation
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
-
1999
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996009047A1 (en) * | 1994-09-19 | 1996-03-28 | The Du Pont Merck Pharmaceutical Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| EP0768083A2 (en) * | 1995-07-17 | 1997-04-16 | Pfizer Inc. | The use of sertraline to treat post myocardial infarction patients |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7115565B2 (en) | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability | |
| US5391377A (en) | Biphasic release formations for lipophilic acids | |
| KR102636273B1 (ko) | 플로로글루시놀 및 트리메틸플로로글루시놀의 제약 제제 | |
| ES2326783T3 (es) | Composiciones de n-benzoilestaurosporina espontaneamente dispersables. | |
| JP2005225897A (ja) | サイクロスポリンａを含む無油医薬組成物 | |
| JP2002531515A (ja) | 水に難溶性の薬剤のための自己乳化組成物 | |
| AP945A (en) | Encapsulated solution dosage forms of sertraline. | |
| JP2004520398A (ja) | 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物 | |
| JPH0840936A (ja) | 経口投与薬物のための製剤 | |
| US20030133974A1 (en) | Encapsulated solution dosage forms of sertraline | |
| US4699776A (en) | Suppositories containing analgesics, antipyretics or anti-inflammatory agents | |
| MXPA99012099A (en) | Gelatine encapsulated solution dosage forms of sertraline | |
| STRICKLEY et al. | Solubilizing vehicles for oral formulation development | |
| JP2022531685A (ja) | メチルナルトレキソンの液体経口投与製剤 | |
| CZ464299A3 (cs) | Želatinové zapouzdření roztokové dávkovači formy sertralinu | |
| AU2922800A (en) | Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter | |
| TW200922637A (en) | Pharmaceutical composition with enhanced bioavailability | |
| AU2002249926A1 (en) | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |